Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2010 | 2 |
2012 | 1 |
2013 | 1 |
2025 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Sustained safety and efficacy of once-daily hydromorphone extended-release (OROS® hydromorphone ER) compared with twice-daily oxycodone controlled-release over 52 weeks in patients with moderate to severe chronic noncancer pain.
Pain Pract. 2013 Jan;13(1):30-40. doi: 10.1111/j.1533-2500.2012.00553.x. Epub 2012 Apr 18.
Pain Pract. 2013.
PMID: 22510252
Clinical Trial.
A randomized study to demonstrate noninferiority of once-daily OROS(®) hydromorphone with twice-daily sustained-release oxycodone for moderate to severe chronic noncancer pain.
Binsfeld H, Szczepanski L, Waechter S, Richarz U, Sabatowski R.
Binsfeld H, et al.
Pain Pract. 2010 Sep-Oct;10(5):404-15. doi: 10.1111/j.1533-2500.2009.00342.x.
Pain Pract. 2010.
PMID: 20384968
Clinical Trial.
Item in Clipboard
Prevention of episodic migraine with topiramate: a prospective 24-week, open-label, flexible-dose clinical trial with optional 24 weeks follow-up in a community setting.
Malessa R, Gendolla A, Steinberg B, Schmitt L, Bornhoevd K, Djelani M, Schäuble B; TOPMAT-MIG-3004 investigators.
Malessa R, et al.
Curr Med Res Opin. 2010 May;26(5):1119-29. doi: 10.1185/03007991003676461.
Curr Med Res Opin. 2010.
PMID: 20225996
Item in Clipboard
Cite
Cite
ARTICLE TYPE
ARTICLE LANGUAGE
AGE
Filters on the sidebar will be reset to the default list and any currently applied filters will be cleared.